Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hiroko Hanasaki‐Yamamoto"'
Autor:
Hikari Takeshita, Koichi Yamamoto, Satoko Nozato, Masao Takeda, So‐ichiro Fukada, Tadakatsu Inagaki, Hirotsugu Tsuchimochi, Mikiyasu Shirai, Yoichi Nozato, Taku Fujimoto, Yuki Imaizumi, Serina Yokoyama, Motonori Nagasawa, Go Hamano, Kazuhiro Hongyo, Tatsuo Kawai, Hiroko Hanasaki‐Yamamoto, Shuko Takeda, Toshimasa Takahashi, Hiroshi Akasaka, Norihisa Itoh, Yoichi Takami, Yasushi Takeya, Ken Sugimoto, Hironori Nakagami, Hiromi Rakugi
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 9, Iss 5, Pp 975-986 (2018)
Abstract Background A pharmacologic strategy for age‐related muscle weakness is desired to improve mortality and disability in the elderly. Angiotensin‐converting enzyme 2 (ACE2) cleaves angiotensin II into angiotensin 1‐7, a peptide known to p
Externí odkaz:
https://doaj.org/article/f462c115a2704b1dbcf968ea7abf2745
Autor:
Yuki Imaizumi, Serina Yokoyama, Shuko Takeda, Mikiyasu Shirai, Yasushi Takeya, Hironori Nakagami, Hiroshi Akasaka, Kazuhiro Hongyo, Tadakatsu Inagaki, Toshimasa Takahashi, Hiroko Hanasaki-Yamamoto, Koichi Yamamoto, Taku Fujimoto, Motonori Nagasawa, Yoichi Takami, So-ichiro Fukada, Satoko Nozato, Ken Sugimoto, Tatsuo Kawai, Hikari Takeshita, Norihisa Itoh, Hiromi Rakugi, Go Hamano, Yoichi Nozato, Masao Takeda, Hirotsugu Tsuchimochi
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle. 9:975-986
BACKGROUND A pharmacologic strategy for age-related muscle weakness is desired to improve mortality and disability in the elderly. Angiotensin-converting enzyme 2 (ACE2) cleaves angiotensin II into angiotensin 1-7, a peptide known to protect against
Autor:
Yuki Imaizumi, Mitsuru Ohishi, Norihiro Hayashi, Tatsuo Kawai, Lei Li, Koichi Yamamoto, Yoshiko Fujita, Yoichi Takami, Theodore W. Kurtz, Ken Sugimoto, Chikako Nakama, Hiroko Hanasaki-Yamamoto, Yoshihiro Maekawa, Tatsuya Sawamura, Hironori Nakagami, Atsushi Nakano, Masao Takeda, Hikari Takeshita, Kei Kamide, Hiromi Rakugi, Ryosuke Oguro, Serina Toyama-Yokoyama, Akemi Kakino, Norihisa Itoh, Miyuki Onishi, Yasushi Takeya, Kazuhiro Hongyo
Publikováno v:
The FASEB Journal. 29:3342-3356
The angiotensin II type 1 receptor (AT1) is a 7-transmembrane domain GPCR that when activated by its ligand angiotensin II, generates signaling events promoting vascular dysfunction and the development of cardiovascular disease. Here, we show that th
Autor:
Koichi Yamamoto, Mitsuru Ohishi, Yukihiro Takemura, Yoichi Takami, Ken Sugimoto, Masao Takeda, Hikari Takeshita, Tatsuo Kawai, Kei Kamide, Yasushi Takeya, Kazuhiro Hongyo, Ryosuke Oguro, Hiromi Rakugi, Hiroko Hanasaki-Yamamoto, Yuji Tatara
Publikováno v:
Diabetes
ACE type 2 (ACE2) functions as a negative regulator of the renin-angiotensin system by cleaving angiotensin II (AII) into angiotensin 1–7 (A1–7). This study assessed the role of endogenous ACE2 in maintaining insulin sensitivity. Twelve-week-old
Autor:
Koichi Yamamoto, Akemi Kakino, Hikari Takeshita, Norihiro Hayashi, Lei Li, Atsushi Nakano, Hiroko Hanasaki-Yamamoto, Yoshiko Fujita, Yuki Imaizumi, Serina Toyama-Yokoyama, Chikako Nakama, Tatsuo Kawai, Masao Takeda, Kazuhiro Hongyo, Ryosuke Oguro, Yoshihiro Maekawa, Norihisa Itoh, Yoichi Takami, Miyuki Onishi, Yasushi Takeya
Publikováno v:
FASEB Journal; Aug2015, Vol. 29 Issue 8, p3342-3356, 15p